Bonnecaze Alex K, Willeford Wesley G, Lichstein Peter, Ohar Jill
Department of Internal Medicine, Wake Forest University Baptist Medical Center.
Department of Pulmonary, Critical Care, Allergy and Immunologic Diseases, Wake Forest University Baptist Medical Center.
Cureus. 2017 Mar 2;9(3):e1070. doi: 10.7759/cureus.1070.
Hemophagocytic lymphohistiocytosis (HLH) is a rare and often deadly syndrome characterized by severe inflammation and cytokine dysregulation. The disease is defined by the HLH-2004 criteria, requiring five of eight findings, and is further differentiated into either primary or secondary causes. Primary HLH tends to be of genetic etiology, while secondary HLH results from other insults such as infection. Secondary HLH is most commonly associated with viral infections in immunocompromised patients. Acute cytomegalovirus (CMV) associated HLH in the immunocompetent host is exceedingly rare and only documented in four case reports to date. We describe the fifth documented case of CMV-associated HLH in an immunocompetent patient, and furthermore, we demonstrate that this patient is the first published case of its type to satisfy all eight of HLH-2004 criteria.
噬血细胞性淋巴组织细胞增生症(HLH)是一种罕见且通常致命的综合征,其特征为严重炎症和细胞因子失调。该疾病由HLH-2004标准定义,需要八项指标中的五项,并且可进一步分为原发性或继发性病因。原发性HLH往往具有遗传病因,而继发性HLH则由其他损伤如感染引起。继发性HLH最常见于免疫功能低下患者的病毒感染。免疫功能正常宿主中急性巨细胞病毒(CMV)相关的HLH极为罕见,迄今为止仅有四例病例报告。我们描述了免疫功能正常患者中第五例有记录的CMV相关HLH病例,此外,我们证明该患者是首例满足HLH-2004所有八项标准的此类已发表病例。